Overview

Effects of Dexmedetomidine Used in Continuous Thoracic Paravertebral Blocks

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to explore the effectiveness of dexmedetomidine as an adjunctive analgesic, used in ultrasound-guided continuous thoracic paravertebral blocks for Post-thoracotomy Pain Syndrome(PTPS).
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Weifeng Tu
Treatments:
Anesthetics
Dexmedetomidine
Ropivacaine
Criteria
Inclusion Criteria:

1. ASA Ⅰ~Ⅲ patient undergoing thoracotomy;

2. Written informed consent from the patient or the relatives of the participating
patient.

3. BMI:18~25kg/m2

Exclusion Criteria:

1. Mental illness;

2. Epidural anesthesia or thoracic paravertebral blocks contraindicated;

3. People who have Slow-type arrhythmias or hypotension;

4. People who have lung infection or sleep apnea syndrome;

5. People who have chronic renal failure;

6. Alcohol or drug abuse;

7. Already taking gabapentin, pregabalin, benzodiazepin or antidepression drug;

8. Local anesthetics allergy;